[1] J.U. Marquardt, J.B. Andersen, S.S. Thorgeirsson, Functional and genetic deconstruction of the cellular origin in liver cancer, Nat Rev Cancer, 15 (2015) 653-667.
[2] D. Sia, A. Villanueva, S.L. Friedman, J.M. Llovet, Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis, Gastroenterology, 152 (2017) 745-761.
[3] E. Reinstein, A. Ciechanover, Narrative review: protein degradation and human diseases: the ubiquitin connection, Ann Intern Med, 145 (2006) 676-684.
[4] A. Ciechanover, The unravelling of the ubiquitin system, Nat Rev Mol Cell Biol, 16 (2015) 322-324.
[5] K.E. Wickliffe, A. Williamson, H.J. Meyer, A. Kelly, M. Rape, K11-linked ubiquitin chains as novel regulators of cell division, Trends Cell Biol, 21 (2011) 656-663.
[6] K. Iwai, Diverse ubiquitin signaling in NF-kappaB activation, Trends Cell Biol, 22 (2012) 355-364.
[7] N. Zheng, N. Shabek, Ubiquitin Ligases: Structure, Function, and Regulation, Annu Rev Biochem, 86 (2017) 129-157.
[8] R.J. Deshaies, C.A. Joazeiro, RING domain E3 ubiquitin ligases, Annu Rev Biochem, 78 (2009) 399-434.
[9] K.I. Nakayama, K. Nakayama, Ubiquitin ligases: cell-cycle control and cancer, Nat Rev Cancer, 6 (2006) 369-381.
[10] S.K. Hotton, J. Callis, Regulation of cullin RING ligases, Annu Rev Plant Biol, 59 (2008) 467-489.
[11] J. Jin, T. Cardozo, R.C. Lovering, S.J. Elledge, M. Pagano, J.W. Harper, Systematic analysis and nomenclature of mammalian F-box proteins, Genes Dev, 18 (2004) 2573-2580.
[12] J.R. Skaar, J.K. Pagan, M. Pagano, SCF ubiquitin ligase-targeted therapies, Nat Rev Drug Discov, 13 (2014) 889-903.
[13] Z. Wang, P. Liu, H. Inuzuka, W. Wei, Roles of F-box proteins in cancer, Nat Rev Cancer, 14 (2014) 233-247.
[14] J. Wu, T. Liu, Z. Rios, Q. Mei, X. Lin, S. Cao, Heat Shock Proteins and Cancer, Trends Pharmacol Sci, 38 (2017) 226-256.
[15] M.E. Feder, G.E. Hofmann, Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology, Annu Rev Physiol, 61 (1999) 243-282.
[16] A. Hoter, M.E. El-Sabban, H.Y. Naim, The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease, Int J Mol Sci, 19 (2018).
[17] S.L. Rutherford, S. Lindquist, Hsp90 as a capacitor for morphological evolution, Nature, 396 (1998) 336-342.
[18] M.P. Mayer, L. Le Breton, Hsp90: breaking the symmetry, Mol Cell, 58 (2015) 8-20.
[19] F.H. Schopf, M.M. Biebl, J. Buchner, The HSP90 chaperone machinery, Nat Rev Mol Cell Biol, 18 (2017) 345-360.
[20] A.D. Zuehlke, K. Beebe, L. Neckers, T. Prince, Regulation and function of the human HSP90AA1 gene, Gene, 570 (2015) 8-16.
[21] A. Khandelwal, V.M. Crowley, B.S.J. Blagg, Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?, Med Res Rev, 36 (2016) 92-118.
[22] J. Trepel, M. Mollapour, G. Giaccone, L. Neckers, Targeting the dynamic HSP90 complex in cancer, Nat Rev Cancer, 10 (2010) 537-549.
[23] Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res, 45 (2017) W98-W102.
[24] J.R. Skaar, J.K. Pagan, M. Pagano, Mechanisms and function of substrate recruitment by F-box proteins, Nat Rev Mol Cell Biol, 14 (2013) 369-381.
[25] I. Paul, S.F. Ahmed, A. Bhowmik, S. Deb, M.K. Ghosh, The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity, Oncogene, 32 (2013) 1284-1295.
[26] P.L. Regan, J. Jacobs, G. Wang, J. Torres, R. Edo, J. Friedmann, X.X. Tang, Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma, Int J Oncol, 38 (2011) 105-112.
[27] K.I. Zeller, A.G. Jegga, B.J. Aronow, K.A. O'Donnell, C.V. Dang, An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets, Genome Biol, 4 (2003) R69.
[28] D. Chen, X. Liu, T. Xia, D.S. Tekcham, W. Wang, H. Chen, T. Li, C. Lu, Z. Ning, X. Liu, J. Liu, H. Qi, H. He, H.L. Piao, A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network, iScience, 16 (2019) 177-191.
[29] A. Hirano, K. Yumimoto, R. Tsunematsu, M. Matsumoto, M. Oyama, H. Kozuka-Hata, T. Nakagawa, D. Lanjakornsiripan, K.I. Nakayama, Y. Fukada, FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes, Cell, 152 (2013) 1106-1118.
[30] S.H. Yoo, J.A. Mohawk, S.M. Siepka, Y. Shan, S.K. Huh, H.K. Hong, I. Kornblum, V. Kumar, N. Koike, M. Xu, J. Nussbaum, X. Liu, Z. Chen, Z.J. Chen, C.B. Green, J.S. Takahashi, Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm, Cell, 152 (2013) 1091-1105.